GV- and Arch-backed Pelage Pharma is developing a first-of-its-kind topical stem-cell therapy that could redefine the $10B hair-loss market.

The Tesla mogul could become the world's first trillionaire after shareholders voted Thursday to approve a new CEO pay package.